Novo Nordisk A/S
Tablet formulation comprising a GLP-1 peptide and a delivery agent
Last updated:
Abstract:
The present invention relates to solid compositions comprising a GLP-1 peptide and a delivery agent, such as SNAC, as well as uses thereof.
Status:
Grant
Type:
Utility
Filling date:
20 Apr 2018
Issue date:
15 Jun 2021